MAGLIO, ANGELANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 103
AS - Asia 66
EU - Europa 61
Totale 230
Nazione #
US - Stati Uniti d'America 103
SG - Singapore 58
IT - Italia 36
IE - Irlanda 5
DE - Germania 4
SE - Svezia 4
FI - Finlandia 3
GB - Regno Unito 3
HK - Hong Kong 3
CZ - Repubblica Ceca 2
FR - Francia 2
NL - Olanda 2
PK - Pakistan 2
CN - Cina 1
CY - Cipro 1
IN - India 1
Totale 230
Città #
Singapore 41
Santa Clara 23
Chandler 10
Milan 8
Lawrence 6
Princeton 6
Dublin 5
Wilmington 5
Chicago 4
Palermo 4
Helsinki 3
Houston 3
London 3
Rome 3
San Nicola Manfredi 3
Boardman 2
Fisciano 2
Hanover 2
Hong Kong 2
Lamezia Terme 2
Messina 2
Olomouc 2
Ashburn 1
Des Moines 1
Islamabad 1
Munich 1
Naples 1
Sezze 1
Totale 147
Nome #
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 22
Tezepelumab: A potential new biological therapy for severe refractory asthma 19
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 18
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 18
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 15
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 15
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 14
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 14
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 14
Phenotyping severe asthma: a rationale for biologic therapy 12
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 11
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 10
Novel Biological Therapies for Severe Asthma Endotypes 9
Novel Biological Therapies for Severe Asthma Endotypes 9
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 8
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 8
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 7
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 7
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 7
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 6
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 6
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 6
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 4
Totale 259
Categoria #
all - tutte 4.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 2 0 0 0 0 0 0 0 0
2021/202223 0 0 2 4 2 1 1 5 3 3 2 0
2022/202344 14 3 8 0 2 1 1 2 3 1 8 1
2023/202447 13 4 6 2 2 6 1 2 1 4 4 2
2024/2025142 22 4 0 4 32 43 13 7 13 4 0 0
Totale 259